Science Explorer Back to mapMap
Discussion
Researcher · Centre for DNA Fingerprinting and Diagnostics · India

Subbareddy Maddika

Subbareddy Maddika publishes mostly in Molecular Biology, Cell Biology and Oncology, on topics such as Ubiquitin and proteasome pathways, PI3K/AKT/mTOR signaling in cancer and Microtubule and mitosis dynamics.

ORCID 0000-0002-5880-391X OpenAlex
World rank
#1,217,765
of 7,710,434 ranked researchers
Rank in India
#18,046
of 280,097
Works
72
Citations
3.7k
Citations per work
51.1
h-index
30
i10-index 41Top 15% in Molecular Biology
Subbareddy Maddika

What does Subbareddy Maddika research?

Subbareddy Maddika's work is mostly in Biochemistry, Genetics and Molecular Biology (70%), Medicine (10%), Agricultural and Biological Sciences (2%).

Life Sciences: 52 works · 72.8% of their workBiochemistry, Genetics and Molecular Biology: 51 works · 70.4% of their workMolecular Biology: 40 works · 56.0% of their workCell Biology: 8 works · 11.4% of their workGenetics: 2 works · 3.0% of their workAgricultural and Biological Sciences: 2 works · 2.4% of their workAnimal Science and Zoology: 2 works · 2.4% of their workEverything else: 13 works · 17.6% of their workHealth Sciences: 7 works · 9.6% of their workMedicine: 7 works · 9.6% of their workOncology: 5 works · 7.2% of their workEpidemiology: 2 works · 2.4% of their workTHEIR WORKSubbareddyMaddika72works
Life Sciences73%Health Sciences10%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology5170.4%
    2. Agricultural and Biological Sciences22.4%
  2. Everything else1317.6%
    1. Medicine79.6%
  1. 1Molecular Biology56% of their works
  2. 2Cell Biology11% of their works
  3. 3Oncology7% of their works
  4. 4Genetics3% of their works
  5. 5Animal Science and Zoology2% of their works
  6. 6Epidemiology2% of their works

Research topics

Which keywords describe Subbareddy Maddika's research?

The keywords of their largest research topics: Cancer Therapy, Apoptosis, Proteasome, Ubiquitin, Cell Death, mTOR, Signaling and Bcl-2 Family.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Cancer Therapy464 topics
  2. Apoptosis213 topics
  3. Proteasome201 topic
  4. Ubiquitin201 topic
  5. Cell Death132 topics
  6. Signaling111 topic
  7. mTOR111 topic
  8. Bcl-2 Family91 topic
  9. Cell Division91 topic
  10. Microtubules91 topic
  11. Mitochondria91 topic
  12. Cell Cycle81 topic
  13. p5381 topic
  14. Endocytosis61 topic
  15. Membrane Fusion61 topic
  16. Coronavirus41 topic
  17. Endoplasmic Reticulum41 topic
  18. Porcine Reproductive and Respiratory Syndrome Virus41 topic
  19. Stress41 topic

Where does Subbareddy Maddika work?

Subbareddy Maddika's main affiliation in the publication record is Centre for DNA Fingerprinting and Diagnostics, India.

How many publications and citations does Subbareddy Maddika have?

OpenAlex counts 72 works and 3,680 citations for Subbareddy Maddika, an h-index of 30, ranking #1,217,765 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Subbareddy Maddika. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.